Chronic elevation of plasma thioredoxin: Inhibition of chemotaxis and curtailment of life expectancy in AIDS
- 27 February 2001
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 98 (5), 2688-2693
- https://doi.org/10.1073/pnas.041624998
Abstract
Thioredoxin (Trx) is an intracellular redox protein with extracellular cytokine-like and chemokine-like activities. We show here that, although plasma Trx levels are unrelated to survival of HIV-infected individuals with CD4 cell counts above 200/microl blood, survival is significantly impaired (P = 0.003) when plasma Trx is chronically elevated in HIV-infected subjects with CD4 T cell counts below this level (i.e., with Centers for Disease Control (CDC)-defined AIDS). Relevant to the mechanism potentially underlying this finding, we also present data from experimental studies in mice showing that elevated plasma Trx efficiently blocks lipopolysaccharide (LPS)-induced chemotaxis, an innate immune mechanism that is particularly crucial when adaptive immunity is compromised. Thus, we propose that elevated plasma Trx in HIV-infected individuals with low CD4 T cell counts directly impairs survival by blocking pathogen-induced chemotaxis, effectively eliminating the last (innate) barrier against establishment of opportunistic and other infections in these immunodeficient individuals.Keywords
This publication has 37 references indexed in Scilit:
- Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infectionJournal of Hepatology, 2000
- Neutropenia, Neutrophil Dysfunction, and Bacterial Infection in Patients with Human Immunodeficiency Virus Disease: The Role of Granulocyte Colony-Stimulating FactorClinical Infectious Diseases, 2000
- Identification of glutathione S-transferase isozymes and ?-glutamylcysteine synthetase as negative acute-phase proteins in rat liverHepatology, 1998
- REDOX REGULATION OF CELLULAR ACTIVATIONAnnual Review of Immunology, 1997
- Amelioration of ischemia-reperfusion injury by human thioredoxin in rabbit lungThe Journal of Thoracic and Cardiovascular Surgery, 1997
- Changes in antigen densities on leukocyte subsets correlate with progression of HIV diseaseInternational Immunology, 1996
- A CD4+ T cell line-secreted factor, growth promoting for normal and leukemic B cells, identified as thioredoxinInternational Immunology, 1995
- Thioredoxin structure and mechanism: conformational changes on oxidation of the active-site sulfhydryls to a disulfideStructure, 1995
- Diseases associated with HTLV-I: virus, IL-2 receptor dysregulation and redox regulationImmunology Today, 1992
- Basic principles of ROC analysisSeminars in Nuclear Medicine, 1978